Abivax (ABVX) Stock Price Target 2026

The average analyst price target for Abivax is $119.86, 36.4% above the current price. Of 16 analysts, 15 rate it Buy and 1 Hold. Targets range from $16 to $187. The latest change came on Oct 21, 2026, when Wedbush lowered its price target on Abivax from $118 to $96 and kept a Neutral rating.

The Average Analyst Price Target for Abivax is $119.86.

Price Target Range — 12 Quarters

Analyst Consensus — 16 Analysts

3S.Buy

12Buy

1Hold

Consensus RatingMarket Outperform# Analysts16Avg. Consensus PT$119.86Upside to Avg. PT+36.4%

Rating Trend — Last 9 Months

Latest Upgrades and Downgrades for Abivax Stock

See all ratings →

Date	Firm	Analyst	Action	Rating Change	Price Target
Oct 21, 2026	Wedbush	David Nierengarten	PT Cut	Neutral	$118→$96
Oct 20, 2026	Guggenheim	Yatin Suneja	Maintained	Buy	$175
Sep 22, 2026	Truist Securities	Gregory Renza	PT Cut	Buy	$155→$151
Sep 22, 2026	Wedbush	David Nierengarten	PT Cut	Neutral	$140→$118
Sep 22, 2026	Barclays	Etzer Darout	Maintained	Overweight	$148
Sep 10, 2026	Goldman Sachs	Rajan Sharma	Initiate	Buy	$155
Sep 5, 2026	BTIG	Julian Harrison	Maintained	Buy	$175
Jul 9, 2026	Piper Sandler	Allison Bratzel	PT Raise	Overweight	$165→$175
Jul 2, 2026	Truist Securities	Gregory Renza	PT Raise	Buy	$135→$155
Jul 1, 2026	Citizens	Jason N. Butler	Maintained	Market Outperform	$187
Jun 30, 2026	Jefferies	Faisal Khurshid	Upgrade	Hold→Buy	$108→$158
Jun 30, 2026	Leerink Partners	Thomas Smith	PT Raise	Outperform	$140→$148
Jun 30, 2026	Wedbush	David Nierengarten	PT Raise	Neutral	$90→$110
Jun 30, 2026	BTIG	Julian Harrison	PT Raise	Buy	$150→$175
Jun 16, 2026	BTIG	Julian Harrison	Maintained	Buy	$150
Jun 2, 2026	Truist Securities	Gregory Renza	PT Cut	Buy	$140→$135
Jun 2, 2026	Jefferies	Faisal Khurshid	Downgrade	Buy→Hold	$160→$90
Jun 2, 2026	Morgan Stanley	Judah Frommer	PT Cut	Overweight	$145→$132
Jun 2, 2026	Wedbush	David Nierengarten	Upgrade	Underperform→Neutral	$110→$90
Jun 2, 2026	Citizens	Jason N. Butler	PT Raise	Market Outperform	$131→$187